Resistance of ERG24 sterol C-14 reductase to heterocyclic amine antifungals.

Arnold CJ, Chartrain L, Lawson DM, Brown JKM

Treatment-Related Adverse Events and Associated Outcomes in Patients With Advanced Urothelial Carcinoma Treated With Enfortumab Vedotin: Analysis of the UNITE Study.

Nizam A, Nguyen CB, Li J, Zabor EC, Msaouel P, Jiang CY, Alhalabi O, Oh E, Davidsohn MP, Epstein IB, Bakaloudi DR, Talukder R, Jindal T, Taylor AK, Glover MJ, Khaki AR, Lemke E, Mabey H, Abuqayas B, Jang A, Brown JR, Evans ST, Pywell C, Basu A, Bilen MA, Barata PC, Zakharia Y, Milowsky MI, Kilari D, Hoimes CJ, Shah SA, Emamekhoo H, Davis NB, Gupta S, Grivas P, Bellmunt J, Campbell MT, Alva AS, Koshkin VS

Clinical Presentation and Rehabilitation Progression Following Hamstring Injury Assessed by BAMIC in Elite Track and Field.

Giakoumis M, Kelly S, Lee J, Stone B, Polglass G, Brown J, MacDonald B, Pollock N

Analysis of Long-term Follow-up of a Randomized Clinical Trial With Departures From Assigned Treatments: Estimation of Metformin Effects on Diabetes and Its Complications in the Diabetes Prevention Program Outcomes Study.

Knowler WC, Pan Q, Shu S, Tripputi MT, Dabelea D, Edelstein SL, Kahn SE, Kuo S, Luchsinger JA, Shah V, Wallia A, Temprosa M, Diabetes Prevention Program Research Group

Impact of Parental or First-Degree Family History of Diabetes on Diabetes Incidence and Progression During Long-term Follow-up in the Diabetes Prevention Program Outcomes Study.

Dagogo-Jack S, Kazemi EJ, Doherty L, Srikanthan P, Echouffo-Tcheugui JB, Knowler WC, Kahn SE, Mudaliar S, Temprosa M, DPP Research Group

Contraceptive Prescribing and Dispensing After the Defense Health Agency's Policy Change.

Juneau R, Kc G, Rittel AG, Rittel M, Brown J, Lutgendorf MA, Highland KB, Costantino RC, Gressler LE

Super-Refractory Status Epilepticus Diagnosis, Management, and Prognostication: An International Survey Study.

Woodward MR, Brown JP, Kittner SJ, Badjatia N, Gilmore EJ, Johnson EL, Morris NA

Once-daily dolutegravir/lamivudine fixed-dose formulations in children living with HIV: a pharmacokinetic and safety sub-study nested in the open-label, multicentre, randomised, non-inferiority D3/PENTA 21 trial.

Bevers LAH, Toledo G, Kisekka M, Kaudha E, Ahimbisibwe GM, Deprez I, Arumugan T, Variava E, Violari A, White I, Bbuye D, Nanduudu A, Mulwanyi E, Amuge P, Rutebarika DA, Kekitiinwa A, Kityo C, Musoke P, Archary M, Boles J, Thomason MJ, de Wildt SN, Giaquinto C, Colbers A, Burger DM, Buchanan AM, Chan MK, Jacobs TG, Turkova A, D3 TRIAL TEAM

Supplemental Items Reduce HCAHPS Response Rates, but Response Rates Do Not Affect HCAHPS Scores: A Randomized Experiment.

Beckett MK, Hambarsoomian K, Brown J, Cleary PD, Abel GA, Giordano LA, Elliott MN

Alternating Hemiplegia of Childhood and ATP1A3-Related Diseases: Insights From a Decade of Discovery and Collaboration.

Simpson AJ, McLellan A, Behl KE, Brown J, Clapcote SJ, Cross JH, van den Maagdenberg AMJM, Vezyroglou AN, Balestrini S, Sisodiya SM